Public disclosure of inside information according to article 17 MAR

Biofrontera AG: Biofrontera AG reports result of the capital increase resolved on April 04, 2024

Leverkusen, Germany (pta046/03.06.2024/19:55 UTC+2)

The capital increase from authorized capital resolved by the Management Board and Supervisory Board of Biofrontera AG on April 04, 2024 has been fully placed. According to the preliminary result of the subscription offer, the capital increase is oversubscribed after the exercise of subscription rights and oversubscription rights. 3,038,431 new shares will be issued at a subscription price of EUR 1.10 per share.


Emitter: Biofrontera AG
Hemmelrather Weg 201
51377 Leverkusen
Contact Person: Investor Relations
Phone: +49 (0) 214 87 63 20
ISIN(s): DE000A4BGGM7 (Share)
Stock Exchange(s): Regulated Market in Dusseldorf, Frankfurt; Free Market in Berlin, Munich, Stuttgart, Tradegate